InfuSystem (NYSE:INFU) CEO Purchases $17,660.00 in Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CEO Carrie Lachance bought 2,000 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was purchased at an average price of $8.83 per share, for a total transaction of $17,660.00. Following the acquisition, the chief executive officer directly owned 237,123 shares of the company’s stock, valued at approximately $2,093,796.09. The trade was a 0.85% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Carrie Lachance also recently made the following trade(s):

• On Monday, May 11th, Carrie Lachance purchased 1,000 shares of InfuSystem stock. The shares were acquired at an average cost of $8.46 per share, with a total value of $8,460.00.

InfuSystem Stock Performance

Shares of INFU stock opened at $8.61 on Friday. The firm has a market capitalization of $173.77 million, a price-to-earnings ratio of 143.52 and a beta of 1.49. The stock has a fifty day moving average of $9.63 and a 200 day moving average of $9.18. InfuSystem Holdings, Inc. has a 52 week low of $5.08 and a 52 week high of $11.04. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50.

Analysts Set New Price Targets

Separately, Roth Mkm restated a “buy” rating and set a $15.00 price target (up from $14.00) on shares of InfuSystem in a research report on Tuesday, February 24th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, InfuSystem presently has an average rating of “Moderate Buy” and a consensus price target of $15.00.

Hedge Funds Weigh In On InfuSystem

A number of institutional investors and hedge funds have recently made changes to their positions in INFU. Hillsdale Investment Management Inc. bought a new stake in shares of InfuSystem in the 3rd quarter worth approximately $4,665,000. Arrowstreet Capital Limited Partnership increased its position in InfuSystem by 220.1% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 449,348 shares of the company’s stock valued at $4,655,000 after buying an additional 308,974 shares in the last quarter. Ancora Advisors LLC purchased a new position in InfuSystem during the third quarter valued at $2,096,000. Teton Advisors LLC bought a new stake in InfuSystem in the third quarter worth $1,917,000. Finally, Jane Street Group LLC increased its holdings in shares of InfuSystem by 943.1% during the second quarter. Jane Street Group LLC now owns 186,159 shares of the company’s stock valued at $1,162,000 after acquiring an additional 168,312 shares in the last quarter. Institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.